Enovis (ENOV) Total Current Liabilities (2010 - 2026)
Enovis' (ENOV) quarterly Total Current Liabilities came in at $608.7 million in Q2 2026, up 27.49% year-on-year from $477.4 million in Q2 2025, and up 1.7% on a QoQ basis from $598.5 million in Q4 2025.
Enovis (ENOV) Total Current Liabilities (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Total Current Liabilities data on file, last reported at $608.7 million in Q2 2026.
- On a quarterly basis, Total Current Liabilities rose 27.49% year-over-year to $608.7 million in Q2 2026; TTM through Apr 2026 was $608.7 million, a 27.49% increase from a year earlier, with the FY2025 full-year figure at $598.5 million, up 13.13% from the prior year.
- Total Current Liabilities for Q2 2026 stood at $608.7 million, up from $598.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for ENOV reached as high as $1.5 billion in Q2 2022 and fell as low as $349.5 million in Q1 2023.
- Historically, Total Current Liabilities has averaged $592.0 million across 5 years, with a median of $549.1 million in 2024.
- Across the five-year window, Total Current Liabilities sank 75.9% in 2023 and soared 57.12% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $565.2 million in 2022, then tumbled by 34.61% to $369.6 million in 2023, then jumped by 43.12% to $529.0 million in 2024, then increased by 13.13% to $598.5 million in 2025, then increased by 1.7% to $608.7 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $608.7 million in Q2 2026, $598.5 million in Q4 2025, and $575.4 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 608.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 608.67 Mn |
| Dec 31, 2025 | 598.47 Mn |
| Oct 3, 2025 | 575.44 Mn |
| Jul 4, 2025 | 568.18 Mn |
| Apr 4, 2025 | 477.42 Mn |
| Dec 31, 2024 | 529.00 Mn |
| Sep 27, 2024 | 530.22 Mn |
| Jun 28, 2024 | 518.01 Mn |
| Mar 29, 2024 | 549.13 Mn |
| Dec 31, 2023 | 369.61 Mn |
| Sep 29, 2023 | 355.28 Mn |
| Jun 30, 2023 | 353.67 Mn |
| Mar 31, 2023 | 349.50 Mn |
| Dec 31, 2022 | 565.20 Mn |
| Sep 30, 2022 | 853.92 Mn |
| Jul 1, 2022 | 812.80 Mn |
| Apr 1, 2022 | 1.45 Bn |
| Dec 31, 2021 | 1.02 Bn |
| Oct 1, 2021 | 975.47 Mn |
| Jul 2, 2021 | 899.42 Mn |